Skip to main content

Prof. Dr. Michael Hölzel

Member, Steering-Committee Member

Institute of Experimental Oncology

Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn

michael.hoelzel@ukbonn.de

+49 228 28751393

Website

Michael Hölzel has long-standing research expertise in the field of tumor biology and functional genomics with a particular focus on neural crest derived tumors such as melanoma. Currently his group investigates how the im-mune system crosstalks with the tumor cells in response to danger and proinflammatory signals released by therapy- induced tumor tissue injury. A central hypothesis is that this reciprocal communication drives therapy relapse due to rewiring of survival and differentiation pathways in tumor cells. This knowledge is critically needed for the rational combination of immunotherapies and targeted signal transduction inhibitors in the clinic.

Recent publications

  • The preCDD Network as a Model for Academic Preclinical Cancer Drug Development in Germany.

    Human gene therapy

    Authors: Evelyn Ullrich, Katja Weisel, Michael Hölzel, Thorsten Diegisser, David Krones, Michael Hudecek, Stefan Knapp, Hans Christian Reinhardt

    View this publication
  • Endothelial p16 expression identifies a subgroup of clear cell renal cell carcinoma with favorable prognosis.

    BMC cancer

    Authors: Michael Stoffel, Katharina Baschun, Melina Kehl, Jörg Ellinger, Niklas Klümper, Sebastian Kadzik, Franziska I Winterhagen, Manuel Ritter, Michael Hölzel, Glen Kristiansen, Marieta I Toma

    View this publication
  • Beyond Dose Escalation in Glioblastoma: Lessons Learned from INTRAGO-II and the Case for Targeting Tumor Biology.

    Neuro-oncology

    Authors: Julian Philipp Layer, Matthias Schneider, Michael Hölzel, Ulrich Herrlinger, Frank Winkler

    View this publication